News & events
Patient-centered tapering offers a path toward significant opioid reduction
Gradual dose reduction can effectively minimize opioids for pain management. A randomized clinical trial published in July 2026 in Annals of Internal Medicine evaluated three patient-centered approaches to tapering long-term…
Florida guidance urges cautious use of psychiatric medications and safe deprescribing in youth
In July, the Florida Department of Health released new guidance encouraging clinicians to take a cautious, comprehensive approach before prescribing psychotropic medications to children ages 5–17. Except in emergencies, it…
US Department of Health and Human Services advocates deprescribing of unnecessary psychiatric drugs
On May 4, 2026, the U.S. Department of Health and Human Services (HHS) issued a clinician advisory to reduce continuation of unnecessary psychiatric drug treatment, moving in the direction of…
Hyperbolic tapering gets a cameo at the American Psychiatric Association
Dr. Chris Aiken, a psychiatrist and editor-in-chief of The Carlat Report, an independent source of clinical psychiatry advice, gave a presentation titled "The Much Too Medicated Patient: Rational and Irrational…
International Conference on Deprescribing broadens its interest in psychotropic deprescribing
In late April, 2026, more than 260 researchers, clinicians, public members, students, policy makers, health and community organisation representatives, and patient advocates came to Montréal, Canada to attend the third…
American Society of Clinical Psychopharmacology backs deprescribing
The American Society of Clinical Psychopharmacology's February, 2026 consensus statement in JAMA Network Open represents an important shift in the field by recognizing deprescribing as an essential component of responsible…
Psychiatric deprescribing is on the map
Deprescribing is becoming recognized as a core skill in psychiatry, as clinicians, patients, and policymakers increasingly recognize the importance of reassessing long-term psychotropic medication use and identifying when dose reduction…
Stephen Stahl and Jeffrey Strawn: Deprescribing as a core competency in psychiatry
Stahl’s Deprescriber’s Guide, a recent book by prominent psychopharmacologist Stephen Stahl, MD, PhD, and Jeffrey Strawn, MD, presents deprescribing as a core competency in psychiatry.
Why I founded the Psychotropic Deprescribing Council
Antidepressants, benzodiazepines, sleep drugs, antipsychotics, stimulants, opioids -- medical education has not prepared clinicians for this flood of drugs or their attendant risks. I founded the Psychotropic Deprescribing Council to…
How consultant pharmacist Dr. DeLon Canterbury helps patients safely go off psychotropic drugs
DeLon Canterbury, PharmD, BCGP, a pharmacist with a private deprescribing practice, discusses how he helps patients design a taper schedule and technical aspects of customized psychotropic dosing. He also reviews…
Support us with a donation
As a registered 501(c)3 charity, we rely upon your financial support.
